|
Era
|
---|
I
|
II
|
III
|
IV
|
p-value
|
---|
n (%)
|
9 (1.6%)
|
96 (16.6%)
|
152 (26.2%)
|
323 (55.7%)
|
n.a.
|
HTK
|
0 (0%)
|
8 (8.3%)
|
68 (44.7%)
|
281 (87.0%)
|
<0.0011
|
UW
|
9 (100.0%)
|
88 (91.7%)
|
84 (55.3%)
|
42 (13%)
|
<0.0011
|
3 months mortality
|
3 (33.3%)
|
22 (22.9%)
|
35 (23.0%)
|
32 (9.9%)
|
<0.0011
|
graft loss
|
8 (88.9%)
|
59 (61.5%)
|
75 (49.7%)
|
85 (26.5%)
|
<0.0011
|
3 month graft survival
|
6 (66.7%)
|
68 (70.8%)
|
106 (69.7%)
|
262 (81.1%)
|
0.0211
|
Biliary complications
|
1 (11.1%)
|
33 (34.4%)
|
47 (30.9%)
|
18 (19.4%)
|
0.0991
|
- HTK = Histidine-Tryptophane-Ketoglutarate solution; UW = University of Wisconsin solution; SD = Standard Deviation.
-
1Pearson’s Chi2 Test.